163 related articles for article (PubMed ID: 9678798)
41. Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission.
Singhal S; Henslee-Downey PJ; Powles R; Chiang KY; Godder K; Treleaven J; Kulkarni S; Van Rhee F; Sirohi B; Pinkerton CR; Meller S; Jovanovic B; Mehta J
Bone Marrow Transplant; 2003 May; 31(10):889-95. PubMed ID: 12748665
[TBL] [Abstract][Full Text] [Related]
42. Fatal cytomegalovirus interstitial pneumonia following autologous peripheral blood stem cell transplantation. Fukuoka Bone Marrow Transplantation Group.
Nagafuji K; Eto T; Hayashi S; Tokunaga Y; Gondo H; Niho Y
Bone Marrow Transplant; 1998 Feb; 21(3):301-3. PubMed ID: 9489656
[TBL] [Abstract][Full Text] [Related]
43. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
44. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
45. Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patients.
Holowiecki J; Grosicki S; Sadus-Wojciechowska M; Kachel L; Hellmann A; Mital A; Skotnicki AB; Piatkowska-Jakubas B; Jedrzejczak WW; Paluszewska M; Wach M; Marianska B; Wrzesien-Kus A; Krawczyk-Kulis M; Wojnar J
Transplant Proc; 2005 Dec; 37(10):4482-7. PubMed ID: 16387150
[TBL] [Abstract][Full Text] [Related]
46. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
47. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
48. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
Zengin E; Sarper N
Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
[TBL] [Abstract][Full Text] [Related]
49. [Immunity against diphtheria and tetanus in various age groups after 40 years since implementation of the mass vaccination program].
Fordymacka A
Przegl Epidemiol; 2000; 54(3-4):333-41. PubMed ID: 11349596
[TBL] [Abstract][Full Text] [Related]
50. A preliminary analysis of the balance between Th1 and Th2 cells after CD34+ cell-selected autologous PBSC transplantation.
Endo T; Sato N; Koizumi K; Nishio M; Fujimoto K; Yamamoto S; Sakai T; Bohgaki T; Sawada K; Koike T
Cytotherapy; 2004; 6(4):337-43. PubMed ID: 16146886
[TBL] [Abstract][Full Text] [Related]
51. Reimmunization after blood or marrow stem cell transplantation: reply to S Singhal and J Mehta.
Heininger U
Bone Marrow Transplant; 2000 Apr; 25(8):913. PubMed ID: 10808216
[No Abstract] [Full Text] [Related]
52. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.
Zubair AC; Kao G; Daley H; Schott D; Freedman A; Ritz J
Cytotherapy; 2006; 8(4):399-407. PubMed ID: 16923616
[TBL] [Abstract][Full Text] [Related]
53. Infection after autologous blood-derived stem cell transplantation.
D'Antonio D; Iacone A; Fioritoni G; Angelini A; Dragani A; Betti S; Di Bartolomeo P; Di Bartolomeo G; Accorsi P; Quaglietta AM
Haematologica; 1990; 75 Suppl 1():83-6. PubMed ID: 1972135
[TBL] [Abstract][Full Text] [Related]
54. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
55. Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease.
Ljungman P; Aschan J; Barkholt L; Broliden PA; Gustafsson B; Lewensohn-Fuchs I; Löfgren C; Winiarski J; Ringdén O
Bone Marrow Transplant; 2004 Oct; 34(7):589-93. PubMed ID: 15300234
[TBL] [Abstract][Full Text] [Related]
56. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
57. Myelodysplastic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma.
Przepiorka D; Buadi F; McClune B; Franz G; Walsh W; White F
Bone Marrow Transplant; 2007 Oct; 40(8):759-64. PubMed ID: 17680015
[TBL] [Abstract][Full Text] [Related]
58. Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines.
Brinkman DM; Jol-van der Zijde CM; ten Dam MM; te Boekhorst PA; ten Cate R; Wulffraat NM; Hintzen RQ; Vossen JM; van Tol MJ
J Clin Immunol; 2007 Nov; 27(6):647-58. PubMed ID: 17690955
[TBL] [Abstract][Full Text] [Related]
59. Factors that influence long-term hematopoietic function following autologous stem cell transplantation.
Amigo ML; del Cañizo MC; Caballero MD; Vazquez L; Corral M; Vidriales B; Brufau A; San Miguel JF
Bone Marrow Transplant; 1999 Aug; 24(3):289-93. PubMed ID: 10455368
[TBL] [Abstract][Full Text] [Related]
60. Haematopoietic damage persists 1 year after autologous peripheral blood stem cell transplantation.
del Cañizo C; Lopez N; Caballero D; Fernandez E; Brufau A; Vazquez L; Mateos V; Gutierrez N; San Miguel JF
Bone Marrow Transplant; 1999 May; 23(9):901-5. PubMed ID: 10338045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
